The laboratory automation market stands poised on the brink of a transformative decade, projected to surge in value, reaching an anticipated $12.5 billion by 2032. This robust growth trajectory, characterized by a noteworthy compound annual growth rate (CAGR) of 8.18%, is powered by an amalgamation
Ivan Kairatov's expertise in biopharma, particularly in advancing technologies and innovation within the industry, positions him as a leading figure in the field of biomedical imaging. With a wealth of experience in research and development, Ivan's contributions have greatly impacted the realm of
In the realm of modern medicine, few breakthroughs have garnered as much attention and promise as GLP-1 receptor agonists. Initially developed to combat type 2 diabetes, these medications have broadened their scope to address obesity, cardiovascular issues, and more. Ivan Kairatov, a renowned
The world of regenerative medicine has been animated by a remarkable breakthrough in tissue engineering, involving the creation of liver organoids capable of developing their own vascular systems. Emerging from a collaborative effort between scientists at Cincinnati Children's Hospital Medical
Veranova has announced a major expansion of its Devens, Massachusetts facility, marking a significant step forward in the development and manufacturing of Antibody-Drug Conjugates (ADCs) and highly potent compounds. The company is investing $50 million to extend the facility by 9,000 square feet,
The US FDA's accelerated approval of Datroway (datopotamab deruxtecan) marks a notable advancement in the realm of lung cancer therapy. This approval is groundbreaking, as Datroway is the first TROP2-directed therapy sanctioned for lung cancer in the United States, specifically targeting a segment
